Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)

Interventions

DRUG: Deucrictibant
DRUG: Placebo
DRUG: Deucrictibant
DRUG: Placebo
DRUG: Deucrictibant

Sponsor

Pharvaris Netherlands B.V.